Epix Pharmaceuticals

Updated on Dec 29, 2023

Edit

Comment

Founder Haim Aviv Ceased operations 2009		Founded 1988
Headquarters Lexington, Massachusetts, United States

Epix Pharmaceuticals Inc (formerly Predix Pharmaceuticals Inc) was a pharmaceutical company based in Lexington, Massachusetts.

Its products included the following agents:

PRX-00023—5-HT_1A receptor full agonist (later discovered to be an antagonist): for major depression and generalized anxiety disorder

PRX-03140—5-HT₄ receptor partial agonist: for Alzheimer's disease

PRX-07034—5-HT₆ receptor antagonist: for obesity and cognitive impairment associated with Alzheimer's disease and schizophrenia

PRX-08066—5-HT_2B receptor antagonist: for pulmonary hypertension associated with chronic obstructive pulmonary disease

As of July 2009, the company was in the process of asset liquidation due to insufficient funds to stay afloat.

References

(Text) CC BY-SA